[Pubalgia in athlete treated by atorvastatin].
Andrès
Emmanuel
E
Service de Médecine Interne, Diabète et Maladies métaboliques, Clinique Médicale B, CHRU de Strasbourg, F-67091 Strasbourg Cedex, France. emmanuel.andres@chru-strasbourg.fr
Alt
Martine
M
D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069059:Atorvastatin; D004359:Drug Therapy, Combination; D005602:France; D006538:Heptanoic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced* / Q000188:drug therapy; D017699:Pelvic Pain / Q000139:chemically induced* / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D013177:Sports
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D011241:Prednisone